The Oncology Institute, Inc.
The Oncology Institute, Inc. scores highest on Torque (99) and lowest on Price (0). Its PosiPenta is 65.20 out of 100, better than most similar companies.
On the Penta Grid this week, The Oncology Institute, Inc. is Grid #58 of 837 in the Healthcare sector in United States, and Grid #202 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| The Oncology Institute, Inc. | 65.20 | 0 | 68 | 92 | 99 | 68 |
| Sagimet Biosciences Inc. | 47.34 | 26 | 33 | 72 | 70 | 35 |
| Cytek Biosciences, Inc. | 58.94 | 28 | 71 | 84 | 59 | 54 |
| Sana Biotechnology, Inc. | 30.63 | 15 | 48 | 23 | 25 | 42 |
| Iambic Therapeutics, Inc. | 44.33 | 0 | 26 | 94 | 64 | 38 |
| OmniAb, Inc. | 55.46 | 24 | 50 | 88 | 61 | 54 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -22.17 |
| P/B ratio | -26.30 |
EEarnings
| Trailing EPS | ₹-27.47 |
| Forward EPS | — |
NNitro
| Price | 609.02 |
| 52-week high | 675.32 |
| 52-week low | 219.74 |
| Fall from 52-week high | 9.8% |
TTorque
| Return on equity (ROE) | — |
| Debt-to-equity | -6.60 |
AAnchor
| Beta (price swings) | 0.42 |
| Market cap | ₹6,206 Cr |
| Insider holding | 17.79% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is The Oncology Institute, Inc.'s PosiPenta score?
The Oncology Institute, Inc.'s PosiPenta is 65.20 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does The Oncology Institute, Inc. stand on the Penta Grid?
On the Penta Grid this week, The Oncology Institute, Inc. is Grid #58 of 837 in the Healthcare sector in United States, and Grid #202 of 4,000 in United States.
Which PosiPenta pillar is strongest for The Oncology Institute, Inc.?
Torque (durability), with a score of 99 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for The Oncology Institute, Inc.?
Price (valuation), with a score of 0 out of 100: much weaker than most similar companies.
Has The Oncology Institute, Inc.'s PosiPenta changed since last week?
Yes, it rose 1.83 points, from 63.37 to 65.20.
PositoAI is for research and education only and is not investment advice.